Genomic advances and their impact on clinical trial design

por Mandrekar, Sumithra J, Sargent, Daniel J
Publicado 2009

The Direct Assignment Option as a Modular Design Component: An Example for the Setting of Two Predefined Subgroups

por An, Ming-Wen, Lu, Xin, Sargent, Daniel J., Mandrekar, Sumithra J.
Publicado 2015

Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials

por Ou, Fang-Shu, Tang, Jun, An, Ming-Wen, Mandrekar, Sumithra J.
Publicado 2021

phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpoints

por Yin, Jun, Du, Yu, Qin, Rui, Shen, Shihao, Mandrekar, Sumithra
Publicado 2021

Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials

por Le-Rademacher, Jennifer G., Storrick, Elizabeth M., Jatoi, Aminah, Mandrekar, Sumithra J.
Publicado 2019

Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities

por Ezzalfani, Monia, Zohar, Sarah, Qin, Rui, Mandrekar, Sumithra J, Deley, Marie-Cécile Le
Publicado 2013

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials

por An, Ming-Wen, Tang, Jun, Grothey, Axel, Sargent, Daniel J., Ou, Fang-Shu, Mandrekar, Sumithra J.
Publicado 2019

Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study

por Wieland, Jana, Satele, Daniel, Almodallal, Yahya, Novotny, Paul, Pritzl, Stephanie L., Mandrekar, Sumithra J., Jatoi, Aminah
Publicado 2022

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials

por Le-Rademacher, Jennifer G., Hillman, Shauna, Storrick, Elizabeth, Mahoney, Michelle R., Thall, Peter F., Jatoi, Aminah, Mandrekar, Sumithra J.
Publicado 2020

Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients

por Le‐Rademacher, Jennifer, Lopez, Camden, Wolfe, Eric, Foster, Nathan R., Mandrekar, Sumithra J., Wang, Xiaofei, Kumar, Rajiv, Adjei, Alex, Jatoi, Aminah
Publicado 2020

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

por Boughey, Judy C., Snyder, Rebecca A., Kantor, Olga, Zheng, Linda, Chawla, Akhil, Nguyen, Toan T., Hillman, Shauna L., Hahn, Olwen M., Mandrekar, Sumithra J., Roland, Christina L.
Publicado 2021

Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)

por Sands, Jacob M, Mandrekar, Sumithra J, Kozono, David, Oxnard, Geoffrey R, Hillman, Shauna L, Wigle, Dennis A, Govindan, Ramaswamy, Carlisle, Jennifer, Gray, Jhanelle, Salama, Joseph K, Raez, Luis, Ganti, Apar, Foster, Nathan, Malik, Shakun, Bradley, Jeffrey, Kelly, Karen, Ramalingam, Suresh S, Stinchcombe, Thomas E
Publicado 2021

Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience

por Zahrieh, David, Hillman, Shauna L., Tan, Angelina D., Frank, Jennifer L., Dockter, Travis, Meyers, Bobbi Jo, Cherevko, Cassie L., Peil, Elizabeth S., McCue, Shaylene, Kour, Oudom, Gunn, Heather J., Neuman, Heather B., Chang, George J., Paskett, Electra D., Mandrekar, Sumithra J., Dueck, Amylou C.
Publicado 2022

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

por Ruppert, Amy S., Booth, Allison M., Ding, Wei, Bartlett, Nancy L., Brander, Danielle M., Coutre, Steven, Brown, Jennifer R., Nattam, Sreenivasa, Larson, Richard A., Erba, Harry, Litzow, Mark, Owen, Carolyn, Kuzma, Charles S., Abramson, Jeremy S., Little, Richard F., Smith, Scott E., Stone, Richard M., Byrd, John C., Mandrekar, Sumithra J., Woyach, Jennifer A.
Publicado 2021